Primary and liver metastasis-derived cell lines from Kras G12D; Trp53 R172H; Pdx-1 cre animals undergo apoptosis in response to triptolide

Veena Sangwan, Sulagna Banerjee, Kelsey M. Jensen, Zhiyu Chen, Rohit Chugh, Vikas Dudeja, Selwyn M. Vickers, Ashok Saluja

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives Pancreatic cancer has a 5-year survival rate of less than 5%, partly because of limited chemotherapeutic options, thereby highlighting the need for novel therapies. Triptolide, a diterpene triepoxide that was derived from a Chinese herb, has shown great promise in preclinical testing against pancreatic cancer using immunocompromised animals. Results In this study, we tested the ability of triptolide to induce cell death in cell lines derived from a primary tumor and adjacent liver metastases of immunocompetent animals (Kras G12D, Trp53 R172H, Pdx-1 Cre [KPC]). Both cell lines were more aggressive in their ability to form tumors when compared with other pancreatic cancer cell lines and showed constitutive activation of the nuclear factor κ-light-chain-enhancer of activated B cells pathway. Triptolide induced apoptotic cell death in both cell lines, as evidenced by decreased cell viability as well as increased caspase 3/7 activity, annexin V positivity, and increased terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling positivity in tumors from KPC animals treated with Minnelide. In addition, triptolide decreased levels of HSP70, its transcription factor HSF1, as well as the antiapoptotic proteins Bcl-xL, Bcl-2, and Mcl-1, which are known to be up-regulated in pancreatic cancer. Conclusions The ability of triptolide to cause cell death in cell lines derived from immunocompetent animals further validates its potential as a novel agent against pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)583-589
Number of pages7
JournalPancreas
Volume44
Issue number4
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Apoptosis
Neoplasm Metastasis
Cell Line
Liver
Cell Death
Caspase 7
Neoplasms
DNA Nucleotidylexotransferase
Diterpenes
Annexin A5
Caspase 3
Cause of Death
Cell Survival
B-Lymphocytes
Transcription Factors
Survival Rate
triptolide
Light
Proteins

Keywords

  • cell death
  • genetically engineered mouse model
  • pancreatic cancer
  • triptolide

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Primary and liver metastasis-derived cell lines from Kras G12D; Trp53 R172H; Pdx-1 cre animals undergo apoptosis in response to triptolide. / Sangwan, Veena; Banerjee, Sulagna; Jensen, Kelsey M.; Chen, Zhiyu; Chugh, Rohit; Dudeja, Vikas; Vickers, Selwyn M.; Saluja, Ashok.

In: Pancreas, Vol. 44, No. 4, 01.01.2015, p. 583-589.

Research output: Contribution to journalArticle

@article{8ad07d1eeaa2495fa049bd3960a74fdf,
title = "Primary and liver metastasis-derived cell lines from Kras G12D; Trp53 R172H; Pdx-1 cre animals undergo apoptosis in response to triptolide",
abstract = "Objectives Pancreatic cancer has a 5-year survival rate of less than 5{\%}, partly because of limited chemotherapeutic options, thereby highlighting the need for novel therapies. Triptolide, a diterpene triepoxide that was derived from a Chinese herb, has shown great promise in preclinical testing against pancreatic cancer using immunocompromised animals. Results In this study, we tested the ability of triptolide to induce cell death in cell lines derived from a primary tumor and adjacent liver metastases of immunocompetent animals (Kras G12D, Trp53 R172H, Pdx-1 Cre [KPC]). Both cell lines were more aggressive in their ability to form tumors when compared with other pancreatic cancer cell lines and showed constitutive activation of the nuclear factor κ-light-chain-enhancer of activated B cells pathway. Triptolide induced apoptotic cell death in both cell lines, as evidenced by decreased cell viability as well as increased caspase 3/7 activity, annexin V positivity, and increased terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling positivity in tumors from KPC animals treated with Minnelide. In addition, triptolide decreased levels of HSP70, its transcription factor HSF1, as well as the antiapoptotic proteins Bcl-xL, Bcl-2, and Mcl-1, which are known to be up-regulated in pancreatic cancer. Conclusions The ability of triptolide to cause cell death in cell lines derived from immunocompetent animals further validates its potential as a novel agent against pancreatic cancer.",
keywords = "cell death, genetically engineered mouse model, pancreatic cancer, triptolide",
author = "Veena Sangwan and Sulagna Banerjee and Jensen, {Kelsey M.} and Zhiyu Chen and Rohit Chugh and Vikas Dudeja and Vickers, {Selwyn M.} and Ashok Saluja",
year = "2015",
month = "1",
day = "1",
doi = "10.1097/MPA.0000000000000317",
language = "English (US)",
volume = "44",
pages = "583--589",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Primary and liver metastasis-derived cell lines from Kras G12D; Trp53 R172H; Pdx-1 cre animals undergo apoptosis in response to triptolide

AU - Sangwan, Veena

AU - Banerjee, Sulagna

AU - Jensen, Kelsey M.

AU - Chen, Zhiyu

AU - Chugh, Rohit

AU - Dudeja, Vikas

AU - Vickers, Selwyn M.

AU - Saluja, Ashok

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objectives Pancreatic cancer has a 5-year survival rate of less than 5%, partly because of limited chemotherapeutic options, thereby highlighting the need for novel therapies. Triptolide, a diterpene triepoxide that was derived from a Chinese herb, has shown great promise in preclinical testing against pancreatic cancer using immunocompromised animals. Results In this study, we tested the ability of triptolide to induce cell death in cell lines derived from a primary tumor and adjacent liver metastases of immunocompetent animals (Kras G12D, Trp53 R172H, Pdx-1 Cre [KPC]). Both cell lines were more aggressive in their ability to form tumors when compared with other pancreatic cancer cell lines and showed constitutive activation of the nuclear factor κ-light-chain-enhancer of activated B cells pathway. Triptolide induced apoptotic cell death in both cell lines, as evidenced by decreased cell viability as well as increased caspase 3/7 activity, annexin V positivity, and increased terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling positivity in tumors from KPC animals treated with Minnelide. In addition, triptolide decreased levels of HSP70, its transcription factor HSF1, as well as the antiapoptotic proteins Bcl-xL, Bcl-2, and Mcl-1, which are known to be up-regulated in pancreatic cancer. Conclusions The ability of triptolide to cause cell death in cell lines derived from immunocompetent animals further validates its potential as a novel agent against pancreatic cancer.

AB - Objectives Pancreatic cancer has a 5-year survival rate of less than 5%, partly because of limited chemotherapeutic options, thereby highlighting the need for novel therapies. Triptolide, a diterpene triepoxide that was derived from a Chinese herb, has shown great promise in preclinical testing against pancreatic cancer using immunocompromised animals. Results In this study, we tested the ability of triptolide to induce cell death in cell lines derived from a primary tumor and adjacent liver metastases of immunocompetent animals (Kras G12D, Trp53 R172H, Pdx-1 Cre [KPC]). Both cell lines were more aggressive in their ability to form tumors when compared with other pancreatic cancer cell lines and showed constitutive activation of the nuclear factor κ-light-chain-enhancer of activated B cells pathway. Triptolide induced apoptotic cell death in both cell lines, as evidenced by decreased cell viability as well as increased caspase 3/7 activity, annexin V positivity, and increased terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling positivity in tumors from KPC animals treated with Minnelide. In addition, triptolide decreased levels of HSP70, its transcription factor HSF1, as well as the antiapoptotic proteins Bcl-xL, Bcl-2, and Mcl-1, which are known to be up-regulated in pancreatic cancer. Conclusions The ability of triptolide to cause cell death in cell lines derived from immunocompetent animals further validates its potential as a novel agent against pancreatic cancer.

KW - cell death

KW - genetically engineered mouse model

KW - pancreatic cancer

KW - triptolide

UR - http://www.scopus.com/inward/record.url?scp=84928475724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928475724&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000000317

DO - 10.1097/MPA.0000000000000317

M3 - Article

C2 - 25875797

AN - SCOPUS:84928475724

VL - 44

SP - 583

EP - 589

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 4

ER -